The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1631-1642

  Eto, Hideyuki ^a   Miyata, Masaaki ^a   Shirasawa, Takahiro ^a   Akasaki, Yuichi ^a   Hamada, Narisato ^a   Nagaki, Aya ^a   Orihara, Koji ^a   Biro, Sadatoshi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Angiotensin; Apoptosis; Atherosclerosis; Hypercholesterolemia; Oxidative stress

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; APOLIPOPROTEIN E; COLLAGEN; ELASTIN; GELATINASE A; GELATINASE B; PROCOLLAGEN; PROCOLLAGEN ALPHA1(I); PROCOLLAGEN ALPHA1(III); PROTEIN P22; SERUM AMYLOID A; TROPOELASTIN; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; HYPERCHOLESTEROLEMIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 55449116863     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1631     Document Type: Article

References (36)

1. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
2. Nicenig G, Harrison DG: The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: Oxidative stress and atherogenesis. Circulation 2002; 105: 393-396.
3. Miura S, Saku K, Karnik SS: Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res 2003; 26: 937-943.
4. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW: Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997; 29: 366-373.
5. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W: Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1623-1629.
6. Hernandez-Presa M, Bustos C, Ortego M, et al: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95: 1532-1541.
7. Tummala PE, Chen XL, Sundell CL, et al: Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999; 100: 1223-1229.
8. Ferrario CM: Use of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens 2002; 15: 9S-13S.
9. Takai S, Jin D, Sakaguchi M, et al: Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model. Hypertens Res 2004; 27: 517-522.
10. Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110: 3062-3067.
11. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA: Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004; 110: 3849-3857.
12. Nyby MD, Abedi K, Smutko V, Eslami P, Tuck ML: Vascular angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res 2007; 30: 451-457.
13. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995; 92: 8264-8268.
14. Tangirala RK, Rubin EM, Palinski W: Quantification of atherosclerosis in murine model: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995; 36: 2320-2328.
15. Miyata M, Biro S, Kaieda H, et al: Apolipoprotein J/clusterin is induced in vascular smooth muscles cells after vascular injury. Circulation 2001; 104: 1407-1412.
16. Obata H, Biro S, Arima N, et al: NF-kappa B is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem Biophys Res Commun 1996; 224: 27-32.
17. Eto H, Biro S, Miyata M, et al: Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury. Cardiovasc Res 2003; 59: 200-211.
18. Bohm M, Raghunath M, Sunderkotter C, et al: Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J Biol Chem 2004; 279: 6959-6966.
19. Bunda S, Kaviani N, Hinek A: Fluctuations of intracellular iron modulate elastin production. J Biol Chem 2005; 280: 2341-2351.
20. Rupin A, Paysant J, Sansilvestri-Morel P, et al: Role of NADPH oxidase-mediated superoxide production in the regulation of E-selectin expression by endothelial cells subjected to anoxia/reoxygenation. Cardiovasc Res 2004; 63: 323-330.
21. Wei W, Parvin N, Tsumura K, et al: Induction of C-reactive protein, serum amyloid P component, and kininogens in the submandibular and lacrimal glands of rats with experimentally induced inflammation. Life Sci 2001; 69: 359-368.
22. Kodali R, Hajjou M, Berman AB, et al: Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells. Cardiovasc Res 2006; 69: 706-715.
23. Abe N, Osanai T, Fujiwara T, Kameda K, Matsunaga T, Okumura K: C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin. Life Sci 2006; 78: 1021-1028.
24. Eto H, Miyata M, Kume N, et al: Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem Biophys Res Commun 2006; 341: 591-598.
25. Suzuki J, Otsuka F, Inagaki K, et al: Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion. Hypertens Res 2007; 30: 367-373.
26. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK: Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002; 91: 406-413.
27. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H: Role of oxidative stress in atherosclerosis. Am J Cardiol 2003; 91: 7A-11A.
28. Nakano D, Hayashi T, Tazawa N, et al: Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res 2005; 28: 837-845.
29. Zalba G, San José G, Moreno MU, et al: Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395-1399.
30. Clempus RE, Griendling KK: Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 2006; 71: 216-225.
31. Hitomi H, Fukui T, Moriwaki K, et al: Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells. J Hypertens 2006; 24: 1089-1095.
32. Kusaka I, Kusaka G, Zhou C, et al: Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. Am J Physiol Heart Circ Physiol 2004; 286: H2442-H2451.
33. Naya M, Tsukamoto T, Morita K, et al: Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 2007; 50: 1144-1149.
34. Chabrashvili T, Kitiyakara C, Blau J, et al: Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 2003; 285: R117-R124.
35. Rabbani R, Topol EJ: Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res 1999; 41: 402-417.
36. Keidar S, Attias J, Smith J, Breslow JL, Hayek T: The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 1997; 236: 622-625.